Expert Outlook: CVS Health Through The Eyes Of 11 Analysts
Portfolio Pulse from Benzinga Insights
Analyst ratings for CVS Health (NYSE:CVS) show a mix of bullish to bearish sentiments, with a recent shift towards more bullish ratings. The average 12-month price target is now $79.18, down from $87.00. Analyst actions include adjustments to ratings and price targets, reflecting dynamic market conditions and CVS Health's performance. CVS Health's financial indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management are highlighted, showcasing its strong market presence and financial health.
May 02, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CVS Health's mixed analyst ratings and lowered average price target reflect varied market sentiments. Strong financial indicators suggest a robust market presence and financial health.
The mixed analyst ratings with a recent shift towards more bullish sentiments, combined with a decrease in the average price target, suggest uncertainty in the short-term price direction. However, CVS Health's strong financial indicators, including market capitalization, revenue growth, net margin, ROE, ROA, and effective debt management, underline its financial health and market presence, potentially mitigating negative impacts from the lowered price target.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100